title: Deal watch: J&J and Genmab deal to push forward CD38 as a blood cancer target.
authors.forename: Alexandra
authors.initials: A
authors.lastname: Flemming
mesh_terms: D051997:ADP-ribosyl Cyclase 1 / Q000276:immunology*; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D003299:Cooperative Behavior; D015195:Drug Design; D004345:Drug Industry; D019337:Hematologic Neoplasms / Q000188:drug therapy* / Q000276:immunology; D006801:Humans
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; C556306:daratumumab; D051997:ADP-ribosyl Cyclase 1